> 31%
of European population suffer from sleep disorders
including Obstructive Sleep Apnea, insomnia, Restless Leg Syndrome, Nacrolepsy and REM sleep behavior Disorder
Eur J Neurol. 2026
> 50%
的新加坡、馬來西亞、南韓、中國40歲以上亞洲人患有阻塞性睡眠窒息症。
Lancet Respir Med 2019
46%
的美國 30-69 歲人群(約7660萬人)到2050年將患有阻塞性睡眠窒息症(OSA)。
Lancet Respir Med 2025
醫療保健專業人員
Belun’s flagship product, Belun Sleep System, comprises a FDA 510(k) cleared wearable ring and proprietary deep-learning algorithms, which is FDA 510(k) cleared for obstructive sleep apnea diagnosis and sleep stages. The solutions are now deployed in the U.S., New Zealand, Thailand, Malaysia, Taiwan, and Hong Kong for sleep health diagnosis and evaluating treatment efficacy for patients with chronic diseases.
產品
探索睡眠與健康的奧秘
透過倍靈指環及人工智能開放平台提供服務,讓醫療人員可為患者提供個人化的方案,提高治療效果,讓普通用家可以自我管理健康及減低健康風險
網誌
Informative, helpful, educational sharing about Belun, HST, AI, wellness & technology
客戶評價


